OptimizeRx Corp. (OPRX)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$7.87-1.01%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · OPRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 98.7 | 109.4 | 92.1 | 71.5 | 62.5 | 61.3 | 43.3 | 24.6 | 21.2 | 12.1 | 7.8 | 7.2 | 6.5 | 4.7 | 2.0 | 1.1 |
| Total Revenues | 98.7 | 109.4 | 92.1 | 71.5 | 62.5 | 61.3 | 43.3 | 24.6 | 21.2 | 12.1 | 7.8 | 7.2 | 6.5 | 4.7 | 2.0 | 1.1 |
| Cost of Revenues | 26.4 | 35.8 | 32.7 | 28.6 | 23.5 | 25.7 | 19.2 | 9.2 | — | — | — | — | — | — | — | — |
| Gross Profit | — | 73.6 | 59.4 | 42.9 | 39.0 | 35.6 | 24.1 | 15.4 | 12.2 | 6.0 | 4.3 | 3.6 | 3.3 | 2.8 | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | 33.5 | 27.7 | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — | — | 0.0 | 1.6 | — | — | — | — | — | — | — | — |
| Operating Income | 10.9 | 11.7 | (13.7) | (26.4) | (12.3) | 0.4 | (2.1) | (3.7) | 0.2 | (2.1) | (1.6) | (0.6) | (1.0) | (0.3) | (0.5) | (1.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 5.3 | 6.2 | 1.5 | — | — | — | — | — | — | — | 0.0 | 0.0 | — | 0.0 | 1.0 |
| Interest & Investment Income | 0.3 | 0.4 | 0.3 | 2.2 | 0.9 | 0.0 | 0.1 | 0.3 | 0.0 | 0.0 | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | (0.7) | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (4.1) | (4.7) | (5.7) | 1.2 | 0.9 | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Asset Writedown | — | 0.4 | 7.5 | 6.7 | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 6.8 | 7.0 | (19.4) | (25.2) | (11.4) | 0.4 | (2.2) | (4.0) | 0.2 | (2.1) | (1.5) | (0.6) | (1.0) | — | — | — |
| Income Tax Expense | 2.2 | 1.8 | 0.7 | (7.6) | — | — | — | (0.9) | — | — | — | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | 4.6 | 5.1 | (20.1) | (17.6) | (11.4) | 0.4 | (2.2) | (3.1) | 0.2 | (2.1) | (1.5) | (0.6) | (1.0) | (0.3) | (0.5) | (2.1) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.24 | 0.28 | (1.10) | (1.03) | (0.64) | 0.02 | (0.15) | (0.23) | 0.02 | — | (0.05) | (0.02) | — | — | — | — |
| Diluted EPS | 0.24 | 0.27 | (1.10) | (1.03) | (0.64) | 0.02 | (0.15) | (0.23) | 0.02 | — | — | — | — | — | — | — |
| Revenue per Share | 5.25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 18.8 | 18.6 | 18.3 | 17.1 | 17.8 | 17.2 | 14.8 | 13.4 | 10.8 | — | 29.7 | 24.6 | 22.4 | — | — | — |
| Diluted Weighted Avg Shares | 18.8 | 19.0 | 18.3 | 17.1 | 17.8 | 17.7 | 14.8 | 13.4 | 11.9 | — | — | — | 24.0 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 16.0 | (9.4) | (24.0) | (10.3) | 2.4 | (0.1) | (2.4) | 0.5 | (1.8) | (1.3) | (0.3) | (0.8) | (0.1) | (0.3) | (1.3) |
| EBIT | 10.9 | 11.7 | (13.7) | (26.4) | (12.3) | 0.4 | (2.1) | (3.7) | 0.2 | (2.1) | (1.6) | (0.6) | (1.0) | (0.3) | (0.5) | (1.5) |
| Effective Tax Rate | 31.8% | — | — | 30.2% | — | — | — | 22.2% | — | — | — | 0.0% | 0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.